Position in LLY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$6,115,894
+$1,716,635 QoQ
Shares Held
5,099
+6.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#1,561
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Koshinski Asset Management, Inc. holds $47,150,309 across 10 Drug Manufacturers - General names. LLY ranks #3 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
84,147 | $21,370,813 | |
| 2 | ABBV |
AbbVie Inc.
|
34,655 | $8,720,584 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
5,099 | $6,115,894 | |
| 4 | PFE |
Pfizer Inc
|
146,261 | $3,521,964 | |
| 5 | AMGN |
Amgen Inc
|
9,577 | $3,468,023 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
21,669 | $1,248,567 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,983 | $1,008,572 | |
| 8 | AZN |
Astrazeneca PLC
|
4,741 | $898,988 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,115,894 | 5,099 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $4,399,259 | 4,783 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $5,203,601 | 4,842 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $3,650,955 | 4,785 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,642,743 | 4,673 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $3,536,546 | 4,282 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $3,287,948 | 4,259 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $3,788,279 | 4,276 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $4,191,909 | 4,630 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $3,510,933 | 4,513 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,068,199 | 3,548 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $2,306,973 | 4,295 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $1,943,453 | 4,144 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $1,696,494 | 4,940 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $1,846,394 | 5,047 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,637,444 | 5,064 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $1,727,497 | 5,328 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $1,388,608 | 4,849 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $1,328,894 | 4,811 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $1,099,104 | 4,757 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $876,995 | 3,821 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $922,703 | 4,939 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $519,520 | 3,077 | Shares | Sole | 2021-03-30 | |
| 2020-09-30 | $432,218 | 2,920 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $490,569 | 2,988 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $424,621 | 3,061 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||